Search
Search Results
##search.searchResults.foundPlural##
-
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1291PDF: 500HTML: 204 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2390PDF: 1005HTML: 1652Fig 1: 189Tab I: 216Cover Letter: 207 -
Pseudo-differentiation syndrome
1369PDF: 665HTML: 10850Figure 1: peripheral blood showing myeloblasts with auer rods: 117Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 105Figure 3: CXR showing pulmonary infiltartes with consolidation: 136Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 113Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2128PDF: 999HTML: 4078Cover Letter: 224Figure 1: 235Figure 2: 233Table 1: 205 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4139PDF: 1714HTML: 1026 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
745PDF: 866PDF Supp. Files: 78HTML: 191 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2036PDF: 766HTML: 3117 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1596PDF: 616HTML: 204 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1414PDF: 822HTML: 8662Fig 3 Savini: 175Fig 2 Savini: 181Fig 1 Savini Chest TC: 189Author letter to referees: 188 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1241PDF: 597HTML: 2869ATRA induced Reactive Hemophagocytosis: A Case Report: 200 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4829PDF: 1793HTML: 2716Untitled: 222 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
982PDF: 537HTML: 727 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4833PDF: 1812HTML: 2162 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1257PDF: 1011HTML: 223 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4073PDF: 1155HTML: 1951Fig.1: 219Fig. 2: 113Table 1: 204Table2: 222Table 3: 201 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4101PDF: 1249HTML: 1960Table 1: 200 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1563PDF: 1034HTML: 233 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1317PDF: 1021HTML: 125 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
891PDF: 490HTML: 141Suppl. Files: 327 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1214PDF: 1414Suppl. Files: 150HTML: 73







